Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort

BACKGROUND: The management of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) has changed dramatically with the introduction and widespread use of HER2-targeted therapies. However, there is relatively limited real-world information on patterns of use, effectiveness and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels, Benjamin, Lord, Sarah J, Kiely, Belinda E, Houssami, Nehmat, Haywood, Philip, Lu, Christine Y, Ward, Robyn L, Pearson, Sallie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278255/
https://www.ncbi.nlm.nih.gov/pubmed/28119394
http://dx.doi.org/10.1136/bmjopen-2016-014439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278255/
https://www.ncbi.nlm.nih.gov/pubmed/28119394
http://dx.doi.org/10.1136/bmjopen-2016-014439

Ejemplares similares